Danaher Corporation (DHR) EV/FCF Ratio: 26.79x
Is Danaher Corporation’s EV/FCF ratio high or low?
Danaher Corporation's EV/FCF ratio of 26.79x is 12% below its 5-year average of 30.49x, near the low end of its 5-year range (21.93x–43.96x).
As of Wednesday, June 17, 2026. 15.94% below its 12-month average of 31.87x.
DHR EV/FCF Ratio Chart
DHR Average EV/FCF Ratio Chart
DHR Current vs Average EV/FCF Ratio Chart
DHR EV/FCF Ratio Metrics
EV/FCF RATIO
26.79x
EV/FCF RATIO AVG TTM
31.87x
EV/FCF RATIO AVG 3Y
32.32x
EV/FCF RATIO AVG 5Y
30.49x
EV/FCF RATIO AVG 10Y
28.65x
EV/FCF RATIO AVG 15Y
23.42x
EV/FCF RATIO AVG 20Y
20.48x
CURRENT VS TTM AVG
-15.94%
CURRENT VS 3Y AVG
-17.11%
CURRENT VS 5Y AVG
-12.14%
CURRENT VS 10Y AVG
-6.48%
CURRENT VS 15Y AVG
+14.40%
CURRENT VS 20Y AVG
+30.80%
DHR Competitors' EV/FCF Ratio
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | $128.06B | 26.79x | 31.87x | 32.32x | 30.49x |
| CVS Health Corporation (CVS)vs › | $127.73B | 26.73x | 27.83x | 27.04x | 21.16x |
| Stryker Corporation (SYK)vs › | $115.45B | 28.17x | 37.46x | 45.07x | 44.82x |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $115.02B | 30.36x | 32.23x | 28.38x | 25.09x |
| Bristol-Myers Squibb Company (BMY)vs › | $114.19B | 12.53x | 10.46x | 11.37x | 12.30x |
| Intuitive Surgical, Inc. (ISRG)vs › | $145.70B | 52.23x | 78.91x | 160.14x | 125.07x |
| Pfizer Inc. (PFE)vs › | $148.41B | 22.35x | 19.82x | 27.37x | 21.38x |
| Medtronic plc (MDT)vs › | $103.29B | 22.54x | 27.47x | 27.69x | 28.55x |
| Abbott Laboratories (ABT)vs › | $157.84B | 25.15x | 30.82x | 34.90x | 31.02x |
| Gilead Sciences, Inc. (GILD)vs › | $158.06B | 17.02x | 18.53x | 16.06x | 14.52x |
Cash Flow Valuation Comparison
EV/FCF
26.8x
P/FCF
24.4x
FCF Yield
4.10%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
- EV/FCF accounts for debt and cash through enterprise value
- P/FCF only considers equity value
- EV/FCF can be compared across companies with different debt levels
- Both measure how the market values cash generation
Danaher Corporation EV/FCF Ratio Formula & Definition
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Danaher Corporation EV/FCF Ratio FAQ
- What is the EV/FCF ratio for Danaher Corporation (DHR)?
- The EV/FCF ratio for DHR stock is 26.79x.
- Is Danaher Corporation's EV/FCF ratio high or low?
- Danaher Corporation's EV/FCF ratio of 26.79x is 12% below its 5-year average of 30.49x, near the low end of its 5-year range (21.93x–43.96x).
- What is the TTM average EV/FCF ratio for Danaher Corporation (DHR)?
- The TTM average EV/FCF ratio for DHR stock is 31.87x.
- What is the 3Y average EV/FCF ratio for Danaher Corporation (DHR)?
- The 3Y average EV/FCF ratio for DHR stock is 32.32x.
- What is the 5Y average EV/FCF ratio for Danaher Corporation (DHR)?
- The 5Y average EV/FCF ratio for DHR stock is 30.49x.
- What is the 10Y average EV/FCF ratio for Danaher Corporation (DHR)?
- The 10Y average EV/FCF ratio for DHR stock is 28.65x.
- What is the 15Y average EV/FCF ratio for Danaher Corporation (DHR)?
- The 15Y average EV/FCF ratio for DHR stock is 23.42x.
- What is the 20Y average EV/FCF ratio for Danaher Corporation (DHR)?
- The 20Y average EV/FCF ratio for DHR stock is 20.48x.
Danaher Corporation EV/FCF Ratio History
| DATE | EV/FCF RATIO |
|---|---|
| 2026-06-16 | 26.79x |
| 2026-06-15 | 26.76x |
| 2026-06-12 | 26.62x |
| 2026-06-11 | 26.72x |
| 2026-06-10 | 27.10x |
| 2026-06-09 | 27.74x |
| 2026-06-08 | 27.09x |
| 2026-06-05 | 27.19x |
| 2026-06-04 | 27.50x |
| 2026-06-03 | 26.35x |
| 2026-06-02 | 26.09x |
| 2026-06-01 | 26.59x |
| 2026-05-29 | 26.97x |
| 2026-05-28 | 26.70x |
| 2026-05-27 | 25.69x |
| 2026-05-26 | 25.64x |
| 2026-05-22 | 25.54x |
| 2026-05-21 | 25.71x |
| 2026-05-20 | 25.42x |
| 2026-05-19 | 24.87x |
| 2026-05-18 | 24.44x |
| 2026-05-15 | 24.18x |
| 2026-05-14 | 24.53x |
| 2026-05-13 | 24.73x |
| 2026-05-12 | 24.76x |
| 2026-05-11 | 24.80x |
| 2026-05-08 | 25.42x |
| 2026-05-07 | 26.03x |
| 2026-05-06 | 25.93x |
| 2026-05-05 | 25.89x |
| 2026-05-04 | 25.81x |
| 2026-05-01 | 25.96x |
| 2026-04-30 | 26.47x |
| 2026-04-29 | 26.45x |
| 2026-04-28 | 26.47x |
| 2026-04-27 | 26.69x |
| 2026-04-24 | 26.24x |
| 2026-04-23 | 26.42x |
| 2026-04-22 | 27.15x |
| 2026-04-21 | 28.57x |
| 2026-04-20 | 28.69x |
| 2026-04-17 | 28.95x |
| 2026-04-16 | 28.82x |
| 2026-04-15 | 29.41x |
| 2026-04-14 | 29.47x |
| 2026-04-13 | 29.10x |
| 2026-04-10 | 28.25x |
| 2026-04-09 | 28.71x |
| 2026-04-08 | 29.14x |
| 2026-04-07 | 28.44x |
| 2026-04-06 | 28.59x |
| 2026-04-02 | 28.46x |
| 2026-04-01 | 28.41x |
| 2026-03-31 | 28.25x |
| 2026-03-30 | 27.48x |
| 2026-03-27 | 27.16x |
| 2026-03-26 | 28.04x |
| 2026-03-25 | 27.92x |
| 2026-03-24 | 28.32x |
| 2026-03-23 | 28.31x |
| 2026-03-20 | 28.22x |
| 2026-03-19 | 28.32x |
| 2026-03-18 | 28.51x |
| 2026-03-17 | 29.01x |
| 2026-03-16 | 28.49x |
| 2026-03-13 | 27.94x |
| 2026-03-12 | 27.80x |
| 2026-03-11 | 28.99x |
| 2026-03-10 | 29.01x |
| 2026-03-09 | 29.50x |
| 2026-03-06 | 29.05x |
| 2026-03-05 | 29.93x |
| 2026-03-04 | 30.30x |
| 2026-03-03 | 30.20x |
| 2026-03-02 | 30.47x |
| 2026-02-27 | 31.10x |
| 2026-02-26 | 30.92x |
| 2026-02-25 | 30.95x |
| 2026-02-24 | 30.90x |
| 2026-02-23 | 33.06x |
| 2026-02-20 | 32.86x |
| 2026-02-19 | 33.11x |
| 2026-02-18 | 32.72x |
| 2026-02-17 | 32.41x |
| 2026-02-13 | 33.30x |
| 2026-02-12 | 33.63x |
| 2026-02-11 | 34.35x |
| 2026-02-10 | 34.31x |
| 2026-02-09 | 33.88x |
| 2026-02-06 | 33.87x |
| 2026-02-05 | 33.75x |
| 2026-02-04 | 34.28x |
| 2026-02-03 | 33.87x |
| 2026-02-02 | 34.84x |
| 2026-01-30 | 34.19x |
| 2026-01-29 | 34.30x |
| 2026-01-28 | 35.00x |
| 2026-01-27 | 36.59x |
| 2026-01-26 | 36.73x |
| 2026-01-23 | 36.49x |
| 2026-01-22 | 37.21x |
| 2026-01-21 | 37.49x |
| 2026-01-20 | 36.39x |
| 2026-01-16 | 36.63x |
| 2026-01-15 | 37.18x |
| 2026-01-14 | 36.91x |
| 2026-01-13 | 36.57x |
| 2026-01-12 | 37.05x |
| 2026-01-09 | 36.96x |
| 2026-01-08 | 36.49x |
| 2026-01-07 | 36.57x |
| 2026-01-06 | 36.71x |
| 2026-01-05 | 36.54x |
| 2026-01-02 | 35.83x |
| 2025-12-31 | 35.62x |
| 2025-12-30 | 35.87x |
| 2025-12-29 | 35.86x |
| 2025-12-26 | 35.82x |
| 2025-12-24 | 35.98x |
| 2025-12-23 | 35.89x |
| 2025-12-22 | 35.49x |
| 2025-12-19 | 35.04x |
| 2025-12-18 | 34.97x |
| 2025-12-17 | 34.73x |
| 2025-12-16 | 35.02x |
| 2025-12-15 | 35.57x |
| 2025-12-12 | 35.25x |
| 2025-12-11 | 36.11x |
| 2025-12-10 | 35.83x |
| 2025-12-09 | 34.81x |
| 2025-12-08 | 34.99x |
| 2025-12-05 | 35.24x |
| 2025-12-04 | 35.37x |
| 2025-12-03 | 35.56x |
| 2025-12-02 | 35.29x |
| 2025-12-01 | 34.94x |
| 2025-11-28 | 35.32x |
| 2025-11-26 | 35.56x |
| 2025-11-25 | 35.88x |
| 2025-11-24 | 35.34x |
| 2025-11-21 | 35.40x |
| 2025-11-20 | 34.66x |
| 2025-11-19 | 34.69x |
| 2025-11-18 | 35.14x |
| 2025-11-17 | 34.41x |
| 2025-11-14 | 34.52x |
| 2025-11-13 | 34.52x |
| 2025-11-12 | 34.27x |
| 2025-11-11 | 33.75x |
| 2025-11-10 | 33.10x |
| 2025-11-07 | 32.92x |
| 2025-11-06 | 33.02x |
| 2025-11-05 | 33.24x |
| 2025-11-04 | 33.47x |
| 2025-11-03 | 33.51x |
| 2025-10-31 | 33.69x |
| 2025-10-30 | 33.65x |
| 2025-10-29 | 33.50x |
| 2025-10-28 | 33.91x |
| 2025-10-27 | 34.50x |
| 2025-10-24 | 34.78x |
| 2025-10-23 | 34.74x |
| 2025-10-22 | 34.08x |
| 2025-10-21 | 34.46x |
| 2025-10-20 | 32.70x |
| 2025-10-17 | 34.13x |
| 2025-10-16 | 34.40x |
| 2025-10-15 | 33.69x |
| 2025-10-14 | 33.70x |
| 2025-10-13 | 33.55x |
| 2025-10-10 | 33.15x |
| 2025-10-09 | 33.45x |
| 2025-10-08 | 33.52x |
| 2025-10-07 | 34.09x |
| 2025-10-06 | 34.52x |
| 2025-10-03 | 35.01x |
| 2025-10-02 | 34.32x |
| 2025-10-01 | 34.69x |
| 2025-09-30 | 32.53x |
| 2025-09-29 | 30.73x |
| 2025-09-26 | 30.55x |
| 2025-09-25 | 30.05x |
| 2025-09-24 | 30.70x |
| 2025-09-23 | 31.27x |
| 2025-09-22 | 31.38x |
| 2025-09-19 | 31.80x |
| 2025-09-18 | 32.09x |
| 2025-09-17 | 31.74x |
| 2025-09-16 | 31.38x |
| 2025-09-15 | 31.09x |
| 2025-09-12 | 31.32x |
| 2025-09-11 | 32.07x |
| 2025-09-10 | 31.69x |
| 2025-09-09 | 31.95x |
| 2025-09-08 | 32.59x |
| 2025-09-05 | 32.82x |
| 2025-09-04 | 32.65x |
| 2025-09-03 | 32.71x |
| 2025-09-02 | 33.35x |
| 2025-08-29 | 33.65x |
| 2025-08-28 | 33.57x |
| 2025-08-27 | 33.53x |
| 2025-08-26 | 33.71x |
| 2025-08-25 | 33.93x |
| 2025-08-22 | 34.53x |
| 2025-08-21 | 33.37x |
| 2025-08-20 | 34.47x |
| 2025-08-19 | 34.59x |
| 2025-08-18 | 34.12x |
| 2025-08-15 | 34.41x |
| 2025-08-14 | 34.30x |
| 2025-08-13 | 34.14x |
| 2025-08-12 | 33.63x |
| 2025-08-11 | 32.75x |
| 2025-08-08 | 32.87x |
| 2025-08-07 | 32.57x |
| 2025-08-06 | 32.07x |
| 2025-08-05 | 32.65x |
| 2025-08-04 | 32.41x |
| 2025-08-01 | 32.36x |
| 2025-07-31 | 32.37x |
| 2025-07-30 | 33.38x |
| 2025-07-29 | 33.80x |
| 2025-07-28 | 33.22x |
| 2025-07-25 | 33.60x |
| 2025-07-24 | 33.20x |
| 2025-07-23 | 32.48x |
| 2025-07-22 | 31.30x |
| 2025-07-21 | 31.02x |
| 2025-07-18 | 31.12x |
| 2025-07-17 | 31.82x |
| 2025-07-16 | 31.60x |
| 2025-07-15 | 31.54x |
| 2025-07-14 | 32.26x |
| 2025-07-11 | 33.30x |
| 2025-07-10 | 33.40x |
| 2025-07-09 | 32.73x |
| 2025-07-08 | 32.69x |
| 2025-07-07 | 32.53x |
| 2025-07-03 | 33.06x |
| 2025-07-02 | 32.96x |
| 2025-07-01 | 32.75x |
| 2025-06-30 | 32.23x |
| 2025-06-27 | 32.41x |
| 2025-06-26 | 32.80x |
| 2025-06-25 | 32.73x |
| 2025-06-24 | 32.22x |
| 2025-06-23 | 32.05x |
| 2025-06-20 | 32.06x |
| 2025-06-18 | 31.77x |
| 2025-06-17 | 31.96x |
| 2025-06-16 | 32.75x |
| 2025-06-13 | 32.69x |
| 2025-06-12 | 33.34x |
| 2025-06-11 | 33.28x |
| 2025-06-10 | 32.97x |
| 2025-06-09 | 32.47x |
| 2025-06-06 | 32.00x |
| 2025-06-05 | 31.43x |
| 2025-06-04 | 31.57x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rainer Blair